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self. These mechanisms have been revealed largely from
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BCR is specific for the cell-associated antigen H-2Kk/b
(reviewed by Nemazee, 2000; Nemazee et al., 2000), and
Robert J. Benschop,* Katja Aviszus,*
Xianghua Zhang,* Tim Manser,†
John C. Cambier,*‡§ and Lawrence J. Wysocki*‡§
*Integrated Department of Immunology
National Jewish Medical and Research Center and
the HyHEL10 (MD4) mouse, in which the BCR exhibitsUniversity of Colorado School of Medicine
high affinity (Ka $ 2 3 109 M21) for hen egg lysozymeDenver, Colorado 80206
(HEL) (reviewed by Healy and Goodnow, 1998). Distinct†Kimmel Cancer Institute
BCR-dependent tolerance mechanisms appear to beDepartment of Microbiology and Immunology
operative in the various stages of B cell development.Jefferson Medical College
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marrow by membrane-associated antigen induces re-
ceptor editing and clonal deletion (Nemazee and Burki,
1989; Hartley et al., 1991). Receptor editing involvesSummary
activation of RAG genes and leads to expression of a
BCR with altered antigen specificity (Gay et al., 1993;Available evidence indicates that B cell tolerance is
Tiegs et al., 1993). If this process does not eliminateattained by receptor editing, anergy, or clonal deletion.
autoreactivity before the cell reaches the transitionalHere, we describe a p-azophenylarsonate (Ars)-spe-
stage (mIgMhighmIgDlow/neg), BCR aggregation stimulatescific immunoglobulin transgenic mouse in which B
death by apoptosis (Carsetti et al., 1995; Norvell et al.,cells become anergic as a consequence of cross-reac-
1995; Melamed et al., 1998). Binding of proteinaceoustion with autoantigen in the bone marrow. Developing
antigens (e.g., soluble HEL) to mature B cells in thebone marrow B cells show no evidence of receptor
periphery leads to antigen processing and upregulationediting but transiently upregulate activation markers
of molecules such as CD86, in preparation for collabora-and appear to undergo accelerated development. Ma-
tion with T cells. If these interactions do not occur withinture B cells are present in normal numbers but are
a finite period, i.e., z48 hr, B cells enter a state charac-refractory to BCR-mediated induction of calcium mo-
terized by continued expression of receptors capablebilization, tyrosine phosphorylation, and antibody re-
of binding antigen but incapable of signal transduction,sponses. Activation marker expression and acquisi-
known as anergy. Although these cells bind antigen,tion of the anergic phenotype is prevented in bone
mIgM and mIgD are downregulated usually by z90%marrow cultures by monovalent hapten. In this model,
and 50%, respectively, in the HEL model (Goodnowit appears that induction of anergy in B cells can be
et al., 1988). These receptors fail to transduce signalsprevented by monovalent hapten competing with au-
leading to even the most proximal biochemical conse-toantigen for the binding site.
quences studied, i.e., tyrosine phosphorylation of sig-
naling intermediaries and induction of calcium mobiliza-
Introduction tion and expression of CD86 and MHC class II (Goodnow
et al., 1988; Cooke et al., 1994; Vilen et al., 1997). How-
B cell fate is precisely controlled by constitutive and ever, these anergic cells remain responsive to CD40-
antigen-driven transduction of antigen receptor (BCR) mediated signals (Cooke et al., 1994; Eris et al., 1994).
signals. While constitutive signals transduced by pro- Based on the selective ability of cell membrane-associ-
BCR, pre-BCR, and BCR sustain development and sur- ated and soluble HEL to induce clonal deletion and an-
vival in the B cell lineage, antigen aggregation of BCR ergy, respectively (Goodnow et al., 1988; Hartley et al.,
enhances this signaling to initiate receptor editing, apo- 1991), it has been suggested that antigen avidity is a key
ptosis, anergy, or the immune response (Benschop and determinant of the mode of B cell tolerance induction.
Cambier, 1999). The nature of the antigen-induced re- However, it is clear that B cell developmental stage
sponse depends on the developmental stage of the re- codetermines the fate of B cells encountering antigen
sponding cell, the avidity of the antigen-BCR interaction, (Carsetti et al., 1995; Norvell et al., 1995; Benschop et
and availability of helper T cell signals. This differential al., 1999). The relative importance and interplay of each
responsiveness to antigen plays a critical role in elimi- of these parameters is unclear.
nating autoreactive B cells from the functional reper- In this report, we describe the properties of an immu-
toire, resulting in immunologic tolerance. noglobulin (md/k) Tg mouse expressing a canonical anti-
Immature B cells are exquisitely sensitive to tolerance Ars BCR. In contrast to the immunoglobulin Tg models
induction compared to their mature counterparts (Cam- described, hapten-specific antibodies offer the freedom
bier et al., 1976; Metcalf and Klinman, 1976; Pike et al., to control avidity and affinity. The response elicited by
1982). It appears that multiple mechanisms are at play p-azophenylarsonate (Ars) in A/J mice is a classical ex-
in the induction and maintenance of B cell tolerance to ample of a hapten-specific immune reaction (Kuettner et
al., 1972). It consistently gives rise to a memory immune
response in which approximately z50% of the antibod-‡ To whom correspondence should be addressed (e-mail: cambierj@
ies can be described as “canonical,” and accordinglynjc.org [J. C. C.], wysockil@njc.org [L. J. W.]).
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Figure 1. Generation and Analysis of Ars/A1
Tg Mice
(A) Schematic representation of the 36–71 L
chain and 36–65 H chain constructs used to
generate md Ars-specific Ig-Tg mice (Ars/A1).
(B) Flow cytometric analysis of peripheral
lymphocytes from Ars/A1, k-only, and H
chain–only Tg mice. Spleen and lymph node
(for Ars/A1) were analyzed using B220 and
an anti-idiotypic antibody (E4). Efficiency of
allelic exclusion was determined by analysis
of L chain expression in Ars/A1 mice (k versus
l), as well as by IgM-allotype and antigen
binding capability (gated on B2201 cells) in
the spleen. Numbers represent percentage of
positive cells in each quadrant.
memory B cell development (Manser et al., 1998; Wy- of respective H and k variable region domains for activity
(Leo et al., 1985; Liu et al., 1996). Furthermore, analysessocki et al., 1998). Canonical anti-Ars antibodies are
highly uniform in structure. They are encoded by one using allotype-specific reagents demonstrated good ex-
pression of the ma Tg receptor and nearly complete alleliccombination of VH, D, JH, Vk, and Jk gene segments.
An arginine codon forms the Vk-Jk junction, and the D exclusion (.95%). Virtually no l light chain–expressing
B cells were detected in Ars/A1 mice (Figure 1B). Consis-region is uniform in length. Prior to somatic mutagene-
sis, canonical antibodies only differ at codons 100 and tent with anti-idiotype staining, Ars/A1 B cells, but not
B cells from k-only or H chain–only Tg mice, stained107 at the VH-D and D-JH boundaries, respectively.
Surprisingly, this Ars-specific Tg BCR in which the k with a biotinylated conjugate of Ars8-BSA (Figure 1B),
indicating that both H and L chains are required to gener-chain has multiple mutations is cross-reactive with an
undefined self-antigen that induces an activated/aner- ate an Ars-specific BCR. Together, these data demon-
strate successful expression of both transgenes andgic phenotype in developing bone marrow B cells. This
phenotype can be modulated by the monovalent hapten suggest good allelic exclusion.
Ars-tyrosine, apparently by competing for the BCR bind-
ing site. This model provides the ability to explore toler- Ars/A1 Mice Fail to Mount a Primary
ance with powerful approaches historically applied to Immune Response
anti-hapten immune responses. To assess their ability to mount a primary immune
response, Ars/A1 mice were immunized with an Ars con-
jugate of KLH (Ars14-KLH) emulsified in incompleteResults
Freund’s adjuvant. The immune response to Ars was
examined serologically and by immunohistochemistry.Transgene Expression and Allelic Exclusion
in Ars/A1 Tg Mice Surprisingly, there was virtually no Ars-specific antibody
in the sera of preimmune mice and negligible Ars-spe-Two lines of Tg mice were generated expressing an
unmutated H chain V region gene from hybridoma 36–65 cific IgM titers at d13 postimmunization (Figure 2A). In
one Ars/A1 mouse (out of eight), a low Ars-specific titerin the context of m and d or the heavily mutated k light
chain gene from hybridoma 36–71 (Figure 1A). Inter- was observed preimmunization, which did not increase
significantly upon immunization. In contrast, significantbreeding led to the generation of mice (termed Ars/A1
mice) that expressed both H 1 L transgenes. These anti-Ars IgM titers were obtained from sera of immunized
k-light chain–only Tg littermates (Figure 2A). In addition,animals contained normal numbers of B220-positive
cells in the spleen and lymph nodes. a rapid class-switch to IgG occurred in the k-only Tg
mice. Finally, similar results were obtained using com-Approximately 95% of B cells stained brightly with
the E4 anti-idiotype (Figure 1B), which requires pairing plete Freund’s adjuvant (data not shown). Histochemical
Hapten-Reversible B Cell Anergy
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Figure 2. Ars/A1 Tg Mice Fail to Mount an Immune Response to Ars
Ars/A1 and k-Tg mice were immunized with Ars14-KLH.
(A) Serum was analyzed for the presence of Ars-specific IgM or total immunoglobulin before (day 0) and after immunization (day 13). Values
for individual mice are shown (eight per group) with indicated mean values.
(B) Analysis of the number and size (arbitrary units, see Experimental Procedures) of GC following immunization (mean 6 SEM).
(C) Immunohistochemistry of Ars/A1 and k-Tg spleens postimmunization (day 13). GCs are visualized using PNA stain; successive sections
were stained for anti-idiotype expression. In Ars/A1 cells, B cells surrounding the GC are idiotype positive, whereas cells in the GC appear
negative. In contrast, in k-Tg mice, idiotype-positive cells are found only in the GC. In agreement with receptor downregulation in GCs, idiotype
staining was less prominent in k-Tg mice compared to idiotype-positive cells in Ars/A1.
analyses revealed that germinal centers (GC) were (data not shown). Analysis of CD21/35 expression dem-
onstrated an z6 fold reduction in the number of transi-smaller and fewer in Ars/A1 than in k-only Tg mice (Fig-
ures 2B and 2C), and the few GC that were seen in tional T2 B cells (Loder et al., 1999) in Ars/A1 spleen
compared to k-only Tg animals (Figure 3A). Importantly,Ars/A1 mice appeared idiotype negative (Figure 2C).
Collectively, these results indicate that despite expres- CD80 was upregulated on mature Ars/A1 B cells,
whereas CD86 expression appeared normal. This stain-sion of Ars-specific antigen receptors capable of binding
antigen, Ars/A1 B cells are immunologically compro- ing pattern suggests accelerated peripheral develop-
mised, appearing anergic. ment in Ars/A1 mice, possibly as a consequence of B
cell signaling by an endogenous antigen.
Subsequent analysis of bone marrow from Ars/A1 andAccelerated Peripheral Development and Activation
k-only Tg animals revealed elevated levels of CD80 andMarker Expression on Ars/A1 B Cells In Vivo
CD86 especially on transitional (IgDlow) B cells (FigureAlthough initial analyses of spleen and lymph nodes of
3B). Most pre- and immature B cells (lower quadrants)Ars/A1 animals did not indicate gross abnormalities with
were negative for all activation markers. CD80 and espe-respect to the peripheral B cell compartment, the sero-
cially CD86 expression levels were lower on the recircu-logical and histological observations prompted us to
lating mature B cells (IgDhigh) found in the bone marrowanalyze the phenotype of mature and immature B cells
compared to transitional B cells, consistent with thein these mice more carefully. We compared Ars/A1 and
transience of induced expression of these markersk-only Tg lymphocyte expression of cell surface mole-
(Hathcock et al., 1994). The expression of CD69 wascules indicative of activation status. No differences were
upregulated similarly to CD80, i.e., elevated expressionobserved with respect to B cell expression of B220,
in the transitional B cells in the bone marrow with lowerCD19, CD62L, and CD22 (data not shown). In contrast,
levels in the spleen (data not shown).levels of IgD were higher in Ars/A1 B cells while IgM
These results suggest that in Ars/A1 mice an autoanti-expression was reduced by 40%–60% compared to
gen present in the bone marrow stimulates transientcells from k-only Tg littermates (Figure 3A). In addition,
upregulation of molecules that are important in T-B col-the number of transitional and marginal zone B cells
laboration. Apparently, this stimulation is qualitatively(IgMhighIgDlow/neg ) in the spleen was z10 fold reduced in
or quantitatively inadequate to induce tolerance by re-Ars/A1 spleens (Figure 3A). This was substantiated by
the virtual absence of CD23neg B cells in Ars/A1 spleens ceptor editing or clonal deletion mechanisms because
Immunity
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Figure 3. Activated Phenotype of Splenic and Bone Marrow B Cells in Ars/A1 Mice
Spleen (A) and bone marrow (B) from Ars/A1 and k-only Tg littermates were analyzed by flow cytometry. Analyses of spleen cells show live
(7AADneg) cells, analyzed for IgM, IgD, CD21/CD35, CD80, CD86, and B220. Bone marrow diagrams show live (7AADneg) B2201 cells, analyzed
for CD80 and CD86 by IgD to separate pre- and immature B cells (lower quadrants) from transitional (IgDlow) and mature circulating (IgDhigh) B
cells. (C) Expression of RAG-2 and GaS (control) was analyzed in immediately ex vivo bone marrow cells (5 3 106) from non-Tg A/J and C57/
B6 mice, k-only Tg, Ars/A1 Tg, 3–83md Tg, and 3–83md Tg mice bred onto antigen (H2Kb)-expressing C57/B6 using RT-PCR.
peripheral B cells are normal in number and continue for T-B collaboration and permits accelerated develop-
ment of a peripheral B cell compartment with an intactto express the Tg receptor (Figure 1). To further test this
interpretation, RAG2 expression was analyzed in bone autoreactive BCR.
marrow by RT-PCR. In models of autoantigen-induced
receptor editing, BCR-mediated stimulation of bone Blocking Activation of Bone Marrow B Cells
with Free Haptenmarrow cells results in enhanced expression of RAG2
(Melamed et al., 1997; Benschop et al., 1999). In contrast To explore whether the activated phenotype of Ars/A1
B cells is a consequence of antigen receptor signaling,to control A/J and k-only Tg bone marrow, no RAG2
expression was observed in ex vivo Ars/A1 bone marrow we assessed the ability of monovalent hapten (Ars-tyro-
sine) to modulate activation of in vitro propagated Ars/cells (Figure 3C). The absence of RAG2 in Ars/A1 bone
marrow is typical of a nontolerant immunoglobulin Tg A1 bone marrow B cells. We hypothesized that if the
effects seen are due to autoantigen binding to the BCR,animal (see the 3–83 md control; Figure 3C). In contrast,
RAG2 is readily detected in 3–83 md Tg mice bred onto monovalent hapten may block them. Bone marrow B
cells of Ars/A1 mice developed and expanded normallyantigen-expressing mice (C57/B6), the model for recep-
tor editing (Tiegs et al., 1993). These data demonstrate during the 6 days culture in IL-7 (Benschop et al., 1999).
Cells that developed in medium with IL-7 alone werethat the signal given by the autoantigen is quantitatively
insufficient or qualitatively inappropriate to induce re- capable of binding Ars8-BSA and displayed upregulation
of CD69 and CD80 (Figure 4A, top row), consistent withceptor editing in immature B cells. Instead, this interac-
tion induces transient expression of molecules relevant the in vivo phenotype. However, when propagated in
Hapten-Reversible B Cell Anergy
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Figure 4. Activation of Ars/A1 Bone Marrow
B Cells Blocked by Monovalent Ars-Tyrosine
(A) Bone marrow cells from Ars/A1 mice were
cultured in IL-7 containing medium with or
without Ars-tyrosine (Ars-tyr; 1024 M) or
PABA-tyrosine (PABA-tyr; 1024 M). After 6
days of culture, cells were analyzed by flow
cytometry for ability to bind antigen (Ars8-
BSA) and expression of activation markers
(CD69 and CD80); histograms of live B cells
(7AADnegB2201) are shown (unstained cells
are shown in white; mean fluorescence 4 to
7) with mean fluorescence of the gray curves
indicated.
(B) Analysis of IgM and IgD in 6 day bone
marrow cultures of Ars/A1 (with or without
1024 M Ars-tyr) and 3–83 md Tg mice. The
percentage of positive cells in the upper left
and right quadrants are indicated.
(C) Dose-dependent effect of Ars-tyr on the
frequency of IgD1 cells in 6 day Ars/A1 and
3–83 md bone marrow cultures (black bars;
open bars represent effect of the addition of
PABA-tyr). Mean 6 SEM of two independent
experiments are shown.
the presence of monovalent Ars-tyrosine, the emerging monovalent hapten suggests that the autoantigen binds
the Tg BCR with a low affinity.B cells were CD69 negative and CD80 expression was
z3-fold lower than in the absence of Ars-tyrosine (Figure The unusually high expression of mIgD by peripheral
B cells suggested that B cells in these animals are, in4A, middle row). In contrast, a control hapten, PABA-
tyrosine, had no effect on expression of these activation a sense, hypermature. To explore the role of autoantigen
in generation of this phenotype, we investigated whethermarkers (Figure 4A, bottom row). All three culture condi-
tions yielded equivalent numbers of B cells, and B cells there was any evidence for accelerated B cell develop-
ment in IL-7-driven bone marrow cultures. While in non-from all three cultures bound Ars8-BSA equally well (left
column). These data strongly support the possibility that Tg animals cells accumulate at the late pre-B cell stage
(IgMnegIgDneg) (Rolink et al., 1991), the presence of anan endogenous antigen induces B cell activation in vivo
and in bone marrow cultures of Ars/A1 mice. It is note- immunoglobulin Tg allows cells to become IgM positive
under these culture conditions while largely remainingworthy that the affinity of the Ars/A1 antibody for Ars
is only z2.5 3 105 M21 (Sharon, 1990). Disruption by IgD negative (Melamed et al., 1997; Benschop et al.,
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This interaction was binding-site specific, as revealed
by competition with monovalent Ars-tyrosine. 100-fold
more PABA-tyrosine, which has a much reduced affinity
for the canonical binding site (Wysocki and Sato, 1981),
was required to achieve the same level of competition.
We can infer that the affinity of the bond between the
antibody and ssDNA was low because the concentration
of Ars-tyrosine required to inhibit binding to ssDNA was
z100-fold less than required to inhibit binding to Ars14-
BSA. Consistent with the possibility that ssDNA is the
responsible autoantigen is the fact that 1024 M Ars-
tyrosine completely blocks both the binding to the Ars/
A1 antibody and the response of Ars/A1 B cells to anti-
gen. Whether ssDNA is the actual autoantigen responsi-
ble for B cell activation in this Tg mouse is uncertain,
however, because antibodies that bind DNA often have
secondary specificities (Diamond and Scharff, 1984;
Retter et al., 1996; Santulli-Marotto et al., 1998; Takeda
et al., 1999; Eivazova et al., 2000).
Defective BCR-Mediated Signal Transduction
in Ars/A1 B Cells
Anergic B cells have been analyzed extensively in the
HEL/anti-HEL tolerance model (Goodnow et al., 1988).
In that model, as well as in similar lymphoma models
(Vilen et al., 1997), B cells are refractory to BCR stimula-Figure 5. Binding of ssDNA by the Ars/A1 Antibody
tion as measured by a failure to induce receptor tyrosineThe ability of the Ars/A1 receptor to bind ssDNA and Ars14-BSA
was tested in competition binding assays using an IgG2b correlate. phosphorylation and kinase activation and by elevated
Increasing concentrations of competitor (monovalent Ars-Tyr or basal levels of Erk1 and Erk2 phosphorylation. In addi-
PABA-Tyr) were added to the wells, and binding antibody was de- tion, anergic B cells have elevated basal intracellular
tected using a monoclonal 125I-labeled anti-k. Standard deviation free calcium concentrations ([Ca21]i) as compared towas ,1%. Background counts for binding to polylysine (1054 cpm)
nonanergic counterparts and fail to mobilize Ca21 follow-in A and BSA in B (364 cpm) were subtracted.
ing receptor aggregation (Cooke et al., 1994; Healy et
al., 1997). We therefore analyzed these indicators of B1999). Although numbers of Ars/A1 and 3–83 md cells
cell anergy in mature splenic B cells from Ars/A1 animalswere comparable following a 6 day culture, we observed
and k-only Tg littermates.
an increase in the percentage of IgD1 cells in Ars/A1
Splenic B cells were stimulated using anti-m, lysed,
bone marrow cultures (Figure 4B). The percentage of
and analyzed by immunoblotting with anti-phosphotyro-
IgD1 cells in a nontolerant bone marrow culture (here sine. B cells from Ars/A1 mice displayed a markedly
3–83 md) was 5%–7%, but an increase to z30% was reduced response to BCR ligation compared to B cells
observed in bone marrow cultures from Ars/A1 mice from the k-only Tg mice (Figure 6A). In addition, levels
(Figure 4B). Interestingly, we observed a correlation be- of Erk1 and Erk2 phosphorylation were elevated in un-
tween IgD and activation marker expression in these stimulated Ars/A1 B cells (Figure 6B). Anti-m antibodies
cultures (data not shown) as would have been expected stimulated only modest increases in Erk phosphoryla-
based on the results obtained using ex vivo bone mar- tion in Ars/A1 cells compared to the response of k-only
row (Figure 3B). The increased frequency of IgD1 cells Tg mice. Consistent with findings in the anti-HEL system
was not observed when 1024 M Ars-tyrosine was present (Healy et al., 1997), antigen-stimulated Erk phosphoryla-
(Figure 4B) and was directly correlated with the amount tion in the anergic Ars/A1 cells (Figure 6B). [Ca21]i was
of Ars-tyrosine present in the cultures (Figure 4C). The analyzed in indo-1AM-loaded cells. Baseline [Ca21]i was
control hapten PABA-tyrosine did not block increased clearly elevated in the majority of Ars/A1 B cells,
frequency of IgD1 cells (Figure 4C). Addition of hapten suggesting continuous low-level stimulation or long
to 3–83 md bone marrow cultures did not alter their memory of the BCR aggregation that led to receptor
growth characteristics or phenotypic appearance (data desensitization (Figure 6C). Minimal additional calcium
not shown). These results suggest that an autoantigen mobilization was observed in Ars/A1 B cells following
either induces an advanced state of differentiation or receptor aggregation (Figure 6D). Consistent with a non-
increases longevity or proliferation of cells that have tolerant mature phenotype, B cells from k-only Tg mice
acquired this phenotype. displayed low basal (70–90 nM) [Ca21]i and mounted a
strong response to anti-m. The observations made in
Affinity of Ars/A1 Tg Receptor for ssDNA the k-only Tg mice were similar to those observed in B
In an effort to identify the autoantigen reactive with the cells from non-Tg A/J animals or B cells from nontolerant
Ars/A1 receptor, we tested a corresponding IgG2b iso- 3–83 md mice (data not shown). Together, the data dem-
typic form of this antibody for binding to a panel of onstrate that mature B cells from Ars/A1 Tg mice display
autoantigens in solid-phase radioimmunoassay. A sig- the hallmarks of B cells rendered anergic by a receptor
desensitization mechanism.nificant interaction with ssDNA was observed (Figure 5).
Hapten-Reversible B Cell Anergy
39
Figure 6. Ars/A1 B Cells Display an Anergic
Signaling Phenotype
(A) Western blot analysis of stimulated (10
mg/ml anti-m) versus unstimulated B cells (2 3
106 cell equivalents per lane) showing tyro-
sine phosphorylation and Syk Western blots
for quantitative control.
(B) Western blot analysis of phosphorylated
Erk1 and Erk2 in stimulated (10 mg/ml anti-m
or 2 mg/ml antigen [Ars14-BSA]) and unstimu-
lated cells, as detected with phospho-Erk-
specific antisera. Blots were stripped and
reprobed using Erk1- and Erk2-specific anti-
bodies.
(C and D) Splenic B cells were loaded with
indo-1AM, and mean intracellular calcium
concentration was evaluated using a flow cy-
tometer. In (C), the distribution of [Ca21]i
in Ars/A1 versus k-Tg B cells is shown for
unstimulated cells. In (D), kinetic analysis
of [Ca21]i is shown following the addition of
anti-m (10 mg/ml).
(E and F) (E) Distribution of [Ca21]i and (F)
calcium mobilization responses following ad-
dition of antigen (2 mg/ml Ars14-BSA) were
analyzed in immature B cells from Ars/A1
bone marrow (BM) cultures grown in medium
alone or with the addition of Ars-tyr (see leg-
end Figure 4). Cultured bone marrow from
3–83 md mice was analyzed similarly.
Based on the observations regarding marker expres- mobilization responses are compromised in immature
and transitional B cells from the Ars/A1 Tg animals.sion by cultured bone marrow B cells from Ars/A1 mice
(Figure 4), we analyzed the calcium signaling phenotype This is probably a consequence of BCR stimulation by
endogenous antigen since the normal signaling pheno-of these cells. The majority of cultured bone marrow
cells exhibited high basal [Ca21]i unless they were propa- type can be restored if cells develop in the presence of
free hapten.gated in the presence of free hapten (Figure 6E). Com-
bined with the phenotypic analyses (Figure 4), these
data show that at least some IgMposIgDneg cells display Discussion
elevated baseline in [Ca21]i, suggesting cells are stimu-
lated at the immature stage. Cells propagated without Our results show that the BCR expressed by B cells of
the Ars/A1 Tg mouse is specific not only for Ars but alsofree hapten failed to respond to BCR stimulation by
antigen (Figure 6F) or anti-m (data not shown). When for an unidentified autoantigen that is expressed in the
bone marrow. Even though B cells in this animal popu-Ars/A1 bone marrow cells were propagated in the pres-
ence of 1024 M Ars-tyrosine, basal [Ca21]i was low (Figure late peripheral lymphoid organs at normal frequencies,
they exhibit an activated surface phenotype, with re-6E) and BCR aggregation led to a robust calcium re-
sponse (Figure 6F). Control cells cultured from 3–83 md duced levels of mIgM, and do not mount an immune
response following immunization in vivo. Analysis of pa-immunoglobulin Tg animals were included to demon-
strate resting baseline [Ca21]i as well as the absence rameters of signal transduction demonstrates that Ars/
A1 B cells exhibit high basal intracellular concentrationsof nonspecific stimulation by the antigen. These data
demonstrate that basal [Ca21]i is elevated and calcium of Ca21, and BCR engagement with anti-m, anti-idiotype,
Immunity
40
or antigen fails to induce normal tyrosine phosphoryla- required to determine the precise biological capabilities
of Tg B cells that are defined as “anergic” by acceptedtion and calcium mobilization. These observations indi-
cate that an autoantigen induces a physiological state standards.
Although the Ars/A1 hybrid antibody binds ssDNAin these B cells that closely resembles or is equivalent
to the anergic status of B cells in the HEL/anti-HEL with low affinity, this is not necessarily the natural au-
toantigen that induces tolerance in Ars/A1 mice. ssDNAtolerance model (Healy and Goodnow, 1998).
Our observations demonstrate that in the Ars/A1 is unlikely to be stable in vivo, although it may be pre-
sented on dying cells (Casciola-Rosen et al., 1994). Inmodel B cells encounter antigen at the immature stage,
when they first express a mature BCR, in the bone mar- addition, unmutated canonical antibodies such as mAb
36-65 also bind ssDNA with similar avidity (unpublishedrow, similar to what was observed in the HEL/anti-HEL
model (Mason et al., 1992). A significant portion of in data), yet B cells expressing exact receptor correlates
of these antibodies participate effectively in immunevitro cultured Ars/A1 bone marrow B cells, while nega-
tive for IgD, display elevated levels of intracellular Ca21. responses elicited by Ars, and they ultimately give rise
to the most consistent and dominant component of theThis activation through the BCR appears to promote B
cell development, as evidenced by increased IgD ex- memory response. Thus, if ssDNA was the natural au-
toantigen responsible for the phenotype of Ars/A1 Bpression in vitro and by the virtual absence of transitional
B cells in the spleen. Peripheral B cell development is cells, this would imply that naturally occurring unmu-
tated canonical B cells have a similar phenotype butan active process and requires signals through the BCR
(Loder et al., 1999). It has been shown that influencing they are nonetheless capable of participating in immune
reactions under appropriate circumstances.the strength of the signal can result in developmental
arrest (e.g., CD452/2 [Loder et al., 1999]) or increased Such a scenario, wherein generated autoreactive B
cells must be silenced, has been put forward to explaindevelopmental progression (e.g., SHIP2/2 [Brauweiler et
al., 2000]). To further illustrate this, it was shown that the existence of anergic B cells (Goodnow, 1996; Good-
now et al., 1991). Indeed, studies in m H-chain Tg micewhile peripheral B cell development is blocked in anti-
HEL Tg mice lacking CD45, additional expression of demonstrated differences between ssDNA- and dsDNA-
reactive B cells with respect to developmental arrest andsoluble HEL promotes accumulation of IgD1 cells (Cys-
ter et al., 1996). This lends supports to our data that their ability to be stimulated through the BCR (Mandik-
Nayak et al., 1997; Roark et al., 1997; Noorchashm etsuggests that augmentation of tonic signals through the
BCR by low-level antigenic stimulation may enhance the al., 1999). It was also demonstrated that severely anergic
anti-dsDNA B cells can be rescued by providing T cellrate of peripheral B cell development (Benschop and
Cambier, 1999). signals in vitro (anti-CD40 and IL-4 [Noorchashm et al.,
1999]), giving credence to the idea that anergy in autore-A major difference between the Ars/A1 mouse and
the HEL/anti-HEL model is the affinity of the anergy- active B cells can be reversed under certain circum-
stances. Antibodies that bind DNA, however, often haveinducing autoantigen: while the affinity of the receptor
for HEL is z2 nanomolar (Goodnow et al., 1988), several secondary specificities for other autoantigens such as
cardiolipin and Sm (Diamond and Scharff, 1984; Retterlines of evidence suggest that the Ars/A1 BCR binds its
natural autoantigen with an affinity that is .10,000-fold et al., 1996; Santulli-Marotto et al., 1998; Takeda et al.,
1999; Eivazova et al., 2000) so it is plausible that thelower. The best evidence for this is the observation that
the activated phenotype in developing bone marrow B Ars/A1 receptor binds another autoantigen in addition
to ssDNA.cells is almost completely precluded by monovalent Ars-
tyrosine at a concentration of 1024 M, despite the fact It is interesting that we find no evidence of receptor
editing in Ars/A1 bone marrow B cells. A similar observa-that the affinity of the Ars/A1 receptor for Ars is low at
z2.5 3 105 M21 (Sharon, 1990). At the same time, 50% tion has been reported in mice expressing an immuno-
globulin m Tg that encodes a BCR with affinity for ssDNAinhibition of binding by this antibody to a multivalent
form of Ars (Ars14-BSA) requires a higher concentration (Erikson et al., 1991). B cells in this mouse, as in the
Ars/A1 mouse, are functionally silenced in vivo but, inof the monovalent hapten (1023 M). Thus, it is likely that
the natural autoantigen has an affinity for the Ars/A1 contrast to the Ars/A1 B cells, express high levels of
IgM (Erikson et al., 1991). Interestingly, when the affinityBCR that is significantly less than 2.5 3 105 M21.
Anti-Ars antibodies that are encoded by canonical H of the Tg receptor for ssDNA is increased, B cells are
deleted or edited in the bone marrow (Chen et al., 1994,and k V region genes are a predominant feature of the
strain A immune response to this hapten. Unmutated 1995). Based on this observation and differences in tol-
erance mechanisms in the HEL model when HEL is se-forms of this structure that are elicited in the early pri-
mary immune response only differ at two junctional co- creted or membrane bound (Goodnow et al., 1988; Hart-
ley et al., 1991), it appears that the degree of BCRdon positions in the H chain. By pairing an unmutated
heavy chain from one antibody (mAb 36-65) with a heav- aggregation is one of the variables that determines the
pathway of tolerance. This would explain the findingsily mutated light chain from another (mAb 36-71), it ap-
pears that we inadvertently generated an autoreactive that in HEL/anti-HEL double-Tg mice immature BM B
cells carry HEL on their receptors, resulting in anergybinding site. An alternative view is that naturally oc-
curring unmutated canonical B cells are slightly autore- in the apparent absence of receptor editing (Mason et
al., 1992). In contrast to the Ars/A1 model, HEL bindingactive and are capable of participating in an immune
response under appropriate circumstances, for exam- at that stage resulted in downmodulation of IgM. It is
likely that in the Ars/A1 mouse, BCR aggregation is mod-ple, if provided with a timely source of activated T cell
help (Bachmann et al., 1993; Goodnow et al., 1991; est due to affinity/valence considerations, and this could
be a major factor that determines their anergic fate.Cooke et al., 1994, 1998). Further experimentation is
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quences by NruI digestion before injection (Figure 1A). The constructCollectively, our data support a scenario wherein Ars/
contained a natural promoter for the VH gene and the naturalA1 B cells encounter antigen at the immature stage in
m-intron enhancer. The VH-D-JH exon carried no somatic mutationsthe bone marrow. Correlated temporally with movement
producing amino acid replacements. FVB-derived eggs were in-
to the transitional stage, they upregulate CD69, CD80, jected with this construct together with a segment of DNA containing
and CD86. Since there are (apparently) no appropriate the Igh 39 enhancer (HS1,2,3b,4 [Madisen and Groudine, 1994]) to
produce a line carrying one copy of the H chain transgene. Preserva-T helper cells in this environment, they fail to make
tion of the original V region sequences in the Tg mouse was con-productive contact. These transitional B cells continue
firmed by PCR amplification and sequencing. H chain transgenicto develop and leave the bone marrow. By the time they
animals were backcrossed for two to three generations onto A/Jreach the spleen, surface CD80 and particularly CD86
strain mice.
have returned to nearly basal levels that may be inade- Light chain: a 14 kb construct containing a functionally rearranged
quate for productive interactions with T cells even if they k light chain from another canonical anti-Ars antibody, mAb36-71,
together with natural intron and 39 enhancers was generated (Figureencounter T cells that recognize class II MHC-peptide
1A) and injected into B6 eggs to produce a second Tg mouse linecomplexes they present. In fact, one might imagine that
carrying three to four copies of the transgene. The Vk-Jk exon inthese B cells should induce tolerance in T cells. We
this construct carried 11 amino acid replacements that were naturalhypothesize that B cell anergy in this model may be
consequences of somatic mutagenesis (Sharon et al., 1989). A B6
the consequence of B cell stimulation by antigen, with mouse homozygous for the mutant k Tg was bred to the heterozy-
consequent transient upregulation of T cell costimula- gous md chain Tg mouse to generate md 1 k double Tg mice, which
we refer to as Ars/A1, and k-only Tg littermate controls.tory molecules and receptor desensitization, followed
by a failed search for T cell help. In this condition, the
Cells and Tissue CultureB cell, expressing too little CD80 or CD86 to elicit helper
Splenic B cells (r . 1.066) were prepared as previously describedactivity from resting T cells and unable to respond again
(Vilen et al., 1997) from 2- to 3-month-old adult mice. Cell viabilityto antigen, is destined to die a failure. Appropriate T cell
was assessed using trypan blue dye exclusion. Immature B cells
help is crucial, and it has been shown that anergic B cells were obtained from IL-7-driven bone marrow cultures as described
can be rescued by timely T cell help in vivo (Goodnow et in detail elsewhere (Benschop et al., 1999).
al., 1991; Bachmann et al., 1993; Cooke et al., 1994;
Cook et al., 1998). Future experiments will address Immunization, Serology, and Immunohistochemistry
Mice (8–12 weeks old) were immunized by a single intraperitonealwhether Ars/A1 B cells can be rescued by T cell help
injection of 100 mg Ars14-KLH in 200 ml PBS in incomplete Freunds’at the transitional stage in the bone marrow.
adjuvant. Pre- (day 0) and post- (day 13) immunization sera wereWe believe that the Ars/A1 model provides a good
analyzed for Ars-specific antibody titers using ELISA. Plates were
approximation of a natural tolerance scenario because coated for 6 hr at room temperature with 1 mg/well Ars14-BSA and
the autoantigen binds the Tg BCR with low affinity. It is blocked with 2%BSA/1%gelatin in PBS for 1 hr at room temperature.
likely that most autoreactive B cells arising from the Serial dilutions of sera and standards were added and plates were
incubated overnight at 48C. The assays were developed with biotin-bone marrow bind self with low affinity based on first
labeled rat-anti-mouse k (clone 187.1, ATCC) and SA-HRP (Southernprinciples. For example, most primary immune re-
Biotechnology, Birmingham, AL). Between steps, plates weresponses are composed of antibodies with low affinity
washed copiously with PBS and developed with ABTS for colorimet-
for immunogen, despite the enhancing power of affinity ric detection. On day 13, the mice were sacrificed. Spleens were
selection. In addition, random pairs of H and L chain V embedded in Tissue-Tek O.C.T. (Fisher Scientific, Pittsburgh, PA),
region genes displayed in phage libraries generally yield frozen in dry ice–cooled 2-methylbutane, and stored at 2708C until
sectioning. Spleens were cut on a cryostat and successive sectionslow affinity products upon an initial screen. Mutagenesis
of 6–8 mm were thaw-mounted on slides. Sections were air-dried,and further rounds of selection applied artificially in vitro
acetone-fixed for 5 min, and stored at 2708C. After thawing, slidesor naturally in vivo are required to achieve antibodies
were rehydrated with 5% normal goat serum in PBS (10 min), and
of high affinity. The capacity of monovalent hapten to the spleens were stained in a humidified chamber for 30 min at
block the appearance of the anergic phenotype in devel- room temperature. The reagents used were PNA-biotin (Vector Lab-
oping bone marrow B cells is an important element of oratories, Burlingame, CA) and anti-idiotype-biotin (5Ci [Wysocki
and Sato, 1981]). After three washes with PBS, the sections werethis model. Ars-tyrosine, present during the IL-7 bone
developed with the ABC Elite Kit followed by DAB detection (Vectormarrow cultures, precluded development of cells with
Laboratories, Burlingame, CA) according to the manufacturer’s pro-an anergic phenotype. Thus, the power of this model
tocols. After counterstaining with hematoxilin, the slides were
may ultimately derive from both its emulation of physio- mounted with Permount. Sections were photographed using a Nikon
logical affinity receptor-antigen interaction and the abil- Diaphot coupled to a Photometrix CCD camera and analyzed using
ity to control B cell perception of an autoantigen in both IPLab Spectrum Version 3.1a. Germinal center areas were mea-
sured; 98% of the GCs were in the range of 0–360 pixels.quantitative and temporal terms.
Experimental Procedures Phenotypic Analysis
Cells were resuspended in PBS containing 1% BSA and 0.1% so-
dium azide and incubated with an optimal amount of biotinylatedGeneration of IgH- and IgL-Chain Tg Mice
Heavy chain: a z50 kb cosmid construct with a VH-D-JH exon from or directly fluorescinated antibody or antigen (Ars8-BSA). Antibodies
directed against the following molecules were used: IgMa (RS3.1,a prototypic canonical anti-Ars antibody (36–65 [Siekevitz et al.,
1983]) in the context of complete m and d constant region genes ATCC); IgMb (AF6-78, BD Pharmingen, San Diego, CA); kappa
(187.1, ATCC); lambda (polyclonal, Southern Biotechnology, Bir-was generated by first replacing the VH-D-JH exon in a previously
described genomic m gene (Durdik et al., 1989) with the correspond- mingham, AL); CD69 (H1.2F3, BD Pharmingen, San Diego, CA); CD86
(GL-1, BD Pharmingen, San Diego, CA); CD80 (16-10A1, BD Phar-ing exon from hybridoma 36–65. This construct was linearized at a
39-proximal Xho I site. It was then ligated to a similarly linearized mingen, San Diego, CA); CD21/CD35 (CR2/CR1; 7G6, BD Phar-
mingen, San Diego, CA); CD19 (1D3, BD Pharmingen, San Diego,3–83 md cosmid construct (Russell et al., 1991) and encapsidated
with a phage l packing extract to produce the desired heavy chain CA); IgM (b-7-6); IgD (JA12.5) or polyclonal (Southern Biotechnology,
Birmingham, AL); CD22 (CY34.1.2, ATTC); CD23 (IgE Fc receptor;cosmid construct, which was then freed of plasmid-derived se-
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B3B4, BD Pharmingen, San Diego, CA); CD45R (anti-B220; RA3- transduction by antigen receptors and their surrogates. Curr. Opin.
Immunol. 11, 143–151.6B2, ATCC); E4 (anti-idiotype [Wysocki and Sato, 1981]); CD62L
(MEL-14, ATCC). Cells were incubated for 30 min at 48C and washed Benschop, R.J., Melamed, D., Nemazee, D., and Cambier, J.C.
twice in PBS/BSA/azide. In the case of biotinylated reagents, cells (1999). Distinct signal thresholds for the unique antigen receptor-
were incubated as before with streptavidin-FITC or -TC (Caltag, linked gene expression programs in mature and immature B cells.
Burlingame, CA). After washing, cells were analyzed on a flow J. Exp. Med. 190, 749–756.
cytometer. Cells were gated on light scatter profile, and dead cells
Brauweiler, A., Tamir, I., Dal Porto, J., Benschop, R.J., Helgason,were excluded using 7AAD stain (Via-Probe, BD Pharmingen, San
C.D., Humphries, R.K., Freed, J.H., and Cambier, J.C. (2000). Differ-Diego, CA).
ential regulation of B cell development, activation, and death by the
src homology 2 domain-containing 59 inositol phosphatase (SHIP).Calcium Mobilization
J. Exp. Med. 191, 1545–1554.For measurements of free intracellular calcium concentration
Cambier, J.C., Kettman, J.R., Vitetta, E.S., and Uhr, J.W. (1976).([Ca21]i), cells were loaded with Indo-1AM (Molecular Probes, Eu-
Differential susceptibility of neonatal and adult murine spleen cellsgene, OR), labeled with anti-B220-PE, suspended at 106 cells/ml in
to in vitro induction of B-cell tolerance. J. Exp. Med. 144, 293–297.IMDM, and analysis initiated using flow cytometry. After the baseline
was established, cells were stimulated with either antigen or anti-m Carsetti, R., Kohler, G., and Lamers, M.C. (1995). Transitional B cells
antibody (b-7-6). Mean [Ca21 ]i was evaluated over time using a are the target of negative selection in the B cell compartment. J.
MoFlo cytometer (Cytomation, Ft. Collins, CO) with appended data Exp. Med. 181, 2129–2140.
acquisition system, and MultiTime software (Phoenix Flow Systems,
Casciola-Rosen, L.A., Anhalt, G., and Rosen, A. (1994). Autoantigens
San Diego, CA) was used for analysis.
targeted in systemic lupus erythematosus are clustered in two popu-
lations of surface structures on apoptotic keratinocytes. J. Exp.
Immunoblotting Med. 179, 1317–1330.
Cells were lysed in 1% NP-40 lysis buffer (150 mM NaCl, 10 mM
Chen, C., Radic, M.Z., Erikson, J., Camper, S.A., Litwin, S., Hardy,Tris [pH 5 7.5], 10 mM sodium pyrophosphate, 2 mM sodium ortho-
R.R., and Weigert, M. (1994). Deletion and editing of B cells thatvanadate, 1 mM PMSF, 10 mM NaF, 0.4 mM EDTA, 1 mM aprotinin,
express antibodies to DNA. J. Immunol. 152, 1970–1982.1 mM a-1-antitrypsin, and 1 mM leupeptin). Lysates were kept on
ice for 15 min before centrifugation at 14,000 rpm for 10 min in an Chen, C., Nagy, Z., Radic, M.Z., Hardy, R.R., Huszar, D., Camper,
Eppendorf centrifuge. Supernatants were mixed with SDS reducing S.A., and Weigert, M. (1995). The site and stage of anti-DNA B-cell
sample buffer and boiled for 5 min. Proteins were separated by SDS- deletion. Nature 373, 252–255.
PAGE, transferred to PVDF, and visualized using specific antibodies Cook, M.C., Basten, A., and Fazekas de St. Groth, B. (1998). Rescue
followed by enhanced chemiluminescence (NEN, Boston, MA). To of self-reactive B cells by provision of T cell help in vivo. Eur. J.
detect tyrosine phosphorylation, the AB-2 anti-phospho-tyrosine Immunol. 28, 2549–2558.
antibody was used (Oncogene, Boston, MA); polyclonal rabbit anti-
Cooke, M.P., Heath, A.W., Shokat, K.M., Zeng, Y., Finkelman, F.D.,Syk was prepared in our laboratory; anti-phospho Erk1/2 was ob-
Linsley, P.S., Howard, M., and Goodnow, C.C. (1994). Immunoglobu-tained from New England Biolabs (Beverly, MA) and used to assess
lin signal transduction guides the specificity of B cell-T cell interac-Erk1/2 phosphorylation, anti-Erk1 and Erk2 were from Santa Cruz
tions and is blocked in tolerant self-reactive B cells. J. Exp. Med.(Santa Cruz, CA).
179, 425–438.
Cyster, J.G., Healy, J.I., Kishihara, K., Mak, T.W., Thomas, M.L., andAnalysis for Recombinase Activator Gene-2 Expression
Goodnow, C.C. (1996). Regulation of B-lymphocyte negative andLevels of recombinase activator gene-2 (RAG-2) and GaS mRNA
positive selection by tyrosine phosphatase CD45. Nature 381,were determined by RT-PCR assay as described in detail elsewhere
325–328.(Hertz and Nemazee, 1997; Melamed et al., 1997).
Diamond, B., and Scharff, M.D. (1984). Somatic mutation of the T15
ssDNA Binding and Hapten Competition Assays heavy chain gives rise to an antibody with autoantibody specificity.
Plates were precoated with 0.1% poly-L-lysine overnight in water. Proc. Natl. Acad. Sci. USA 81, 5841–5844.
ssDNA (10 mg/ml) or Ars14-BSA (10 mg/ml) was added and incubated Durdik, J., Gerstein, R.M., Rath, S., Robbins, P.F., Nisonoff, A., and
for 1 hr. Plates were incubated with 400 ng antibody/well in the
Selsing, E. (1989). Isotype switching by a microinjected mu immuno-
presence or absence of various concentrations of hapten-tyrosine.
globulin heavy chain gene in transgenic mice. Proc. Natl. Acad. Sci.
Antibody binding was detected using 125I-Rat anti-mouse k antibody
USA 86, 2346–2350.
(clone 187.1, ATCC). The amino group of tyrosine was blocked by
Eivazova, E.R., McDonnell, J.M., Sutton, B.J., and Staines, N.A.acetylation prior to conjugation with diazonium salts of Ars and
(2000). Cross-reactivity of antiidiotypic antibodies with DNA in sys-p-aminobenzoic acid-tyrosine (PABA [Wysocki and Sato, 1981]).
temic lupus erythematosus. Arthritis Rheum. 43, 429–439.
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